Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
74.05
-0.27 (-0.36%)
At close: May 22, 2026, 4:00 PM EDT
72.88
-1.17 (-1.58%)
After-hours: May 22, 2026, 7:06 PM EDT
Spyre Therapeutics Market Cap
Spyre Therapeutics has a market cap or net worth of $6.43 billion as of May 22, 2026. Its market cap has increased by 728.58% in one year.
Market Cap
6.43B
Enterprise Value
5.69B
1-Year Change
728.58%
Ranking
Category
Stock Price
$74.05
Market Cap Chart
Since April 7, 2016, Spyre Therapeutics's market cap has increased from $111.70M to $6.43B, an increase of 5,657.02%. That is a compound annual growth rate of 49.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 6.43B | 152.98% |
| Dec 31, 2025 | 2.54B | 112.30% |
| Dec 31, 2024 | 1.20B | 1,274.63% |
| Dec 29, 2023 | 87.10M | 214.44% |
| Dec 30, 2022 | 27.70M | -88.18% |
| Dec 31, 2021 | 234.30M | -37.90% |
| Dec 31, 2020 | 377.30M | 70.42% |
| Dec 31, 2019 | 221.40M | 23.34% |
| Dec 31, 2018 | 179.50M | 99.44% |
| Dec 29, 2017 | 90.00M | 54.11% |
| Dec 30, 2016 | 58.40M | -47.72% |
| Apr 7, 2016 | 111.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunovant | 7.01B |
| Vaxcyte | 6.83B |
| Celcuity | 6.74B |
| Kymera Therapeutics | 6.49B |
| Corcept Therapeutics | 6.46B |
| Protagonist Therapeutics | 6.38B |
| Centessa Pharmaceuticals | 6.15B |
| Apogee Therapeutics | 6.08B |